367 related articles for article (PubMed ID: 32561150)
21. Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis.
Levite M; Ganor Y
Expert Rev Neurother; 2008 Jul; 8(7):1141-60. PubMed ID: 18590483
[TBL] [Abstract][Full Text] [Related]
22. GluR3B Ab's induced oligodendrocyte precursor cells excitotoxicity via mitochondrial dysfunction.
Liu Y; Chen Y; Du WT; Wu XX; Dong FX; Qu XB; Fan HB; Yao RQ
Brain Res Bull; 2017 Apr; 130():60-66. PubMed ID: 28063880
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Structural Changes in Nodding Syndrome and Other Epilepsies Associated With
Mazumder R; Lubowa SK; Salamon N; Jackson NJ; Kawooya M; Akun PR; Anguzu R; Ogwang RJ; Kubofcik J; Nutman T; Marsh K; Newton C; Vincent A; Idro R
Neurol Neuroimmunol Neuroinflamm; 2023 Mar; 10(2):. PubMed ID: 36543539
[TBL] [Abstract][Full Text] [Related]
24. Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines.
Ganor Y; Freilinger M; Dulac O; Levite M
Autoimmunity; 2005 Mar; 38(2):139-50. PubMed ID: 16040334
[TBL] [Abstract][Full Text] [Related]
25. Nodding Syndrome in the Spotlight - Placing Recent Findings in Perspective.
Spencer PS; Schmutzhard E; Winkler AS
Trends Parasitol; 2017 Jul; 33(7):490-492. PubMed ID: 28596064
[TBL] [Abstract][Full Text] [Related]
26. Nodding syndrome in Tanzania may not be associated with circulating anti-NMDA-and anti-VGKC receptor antibodies or decreased pyridoxal phosphate serum levels-a pilot study.
Dietmann A; Wallner B; König R; Friedrich K; Pfausler B; Deisenhammer F; Griesmacher A; Seger C; Matuja W; JilekAall L; Winkler AS; Schmutzhard E
Afr Health Sci; 2014 Jun; 14(2):434-8. PubMed ID: 25320594
[TBL] [Abstract][Full Text] [Related]
27. Identification of amino acids in the glutamate receptor, GluR3, important for antibody-binding and receptor-specific activation.
Carlson NG; Gahring LC; Twyman RE; Rogers SW
J Biol Chem; 1997 Apr; 272(17):11295-301. PubMed ID: 9111034
[TBL] [Abstract][Full Text] [Related]
28. The presence of autoantibodies to N-terminus domain of GluR1 subunit of AMPA receptor in the blood serum of patients with epilepsy.
Dambinova SA; Izykenova GA; Burov SV; Grigorenko EV; Gromov SA
J Neurol Sci; 1997 Nov; 152(1):93-7. PubMed ID: 9395130
[TBL] [Abstract][Full Text] [Related]
29. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
[TBL] [Abstract][Full Text] [Related]
30. Region-specific expression of subunits of ionotropic glutamate receptors (AMPA-type, KA-type and NMDA receptors) in the rat spinal cord with special reference to nociception.
Furuyama T; Kiyama H; Sato K; Park HT; Maeno H; Takagi H; Tohyama M
Brain Res Mol Brain Res; 1993 Apr; 18(1-2):141-51. PubMed ID: 8097549
[TBL] [Abstract][Full Text] [Related]
31. An unusual case of coma related to glutamate receptor 3 (GluR3) auto-antibodies after a traumatic spinal cord injury: Clinical and pathological aspects.
Caputo F; Barranco R; Ricci P; Gratteri S; Castelletti L; Ravetti GL; Ventura F
Med Leg J; 2021 Jun; 89(2):133-136. PubMed ID: 33331219
[TBL] [Abstract][Full Text] [Related]
32. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site.
Twyman RE; Gahring LC; Spiess J; Rogers SW
Neuron; 1995 Apr; 14(4):755-62. PubMed ID: 7718238
[TBL] [Abstract][Full Text] [Related]
33. No effect of immunomodulatory therapy in focal epilepsy with positive glutamate receptor type 3--antibodies.
Feichtinger M; Wiendl H; Körner E; Holl A; Gruber L; Fazekas F; Schröttner O; Eder H; Ott E
Seizure; 2006 Jul; 15(5):350-4. PubMed ID: 16621617
[TBL] [Abstract][Full Text] [Related]
34. The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.
Ganor Y; Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):983-1006. PubMed ID: 24584970
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune seizures and epilepsy.
Geis C; Planagumà J; Carreño M; Graus F; Dalmau J
J Clin Invest; 2019 Mar; 129(3):926-940. PubMed ID: 30714986
[TBL] [Abstract][Full Text] [Related]
36. Glutamate receptor GluR3 antibodies and death of cortical cells.
He XP; Patel M; Whitney KD; Janumpalli S; Tenner A; McNamara JO
Neuron; 1998 Jan; 20(1):153-63. PubMed ID: 9459451
[TBL] [Abstract][Full Text] [Related]
37. Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation.
Gahring L; Carlson NG; Meyer EL; Rogers SW
J Immunol; 2001 Feb; 166(3):1433-8. PubMed ID: 11160179
[TBL] [Abstract][Full Text] [Related]
38. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.
Petit-Pedrol M; Armangue T; Peng X; Bataller L; Cellucci T; Davis R; McCracken L; Martinez-Hernandez E; Mason WP; Kruer MC; Ritacco DG; Grisold W; Meaney BF; Alcalá C; Sillevis-Smitt P; Titulaer MJ; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2014 Mar; 13(3):276-86. PubMed ID: 24462240
[TBL] [Abstract][Full Text] [Related]
39. Intracellular and circulating neuronal antinuclear antibodies in human epilepsy.
Iffland PH; Carvalho-Tavares J; Trigunaite A; Man S; Rasmussen P; Alexopoulos A; Ghosh C; Jørgensen TN; Janigro D
Neurobiol Dis; 2013 Nov; 59():206-19. PubMed ID: 23880401
[TBL] [Abstract][Full Text] [Related]
40. Nodding syndrome (NS) and
Lagoro DK; Arony DA
Pan Afr Med J; 2017; 28():1. PubMed ID: 29138647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
